These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29725394)
1. 4-Methylumbelliferone inhibits enhanced hyaluronan synthesis and cell migration in pancreatic cancer cells in response to tumor-stromal interactions. Cheng XB; Sato N; Kohi S; Koga A; Hirata K Oncol Lett; 2018 May; 15(5):6297-6301. PubMed ID: 29725394 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronan stimulates pancreatic cancer cell motility. Cheng XB; Kohi S; Koga A; Hirata K; Sato N Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359 [TBL] [Abstract][Full Text] [Related]
3. Negative regulation between the expression levels of receptor for hyaluronic acid-mediated motility and hyaluronan leads to cell migration in pancreatic cancer. Cheng XB; Wang S; Yang H; Tong H; Shi G; Wu L; Zhou J; Shi L; Li H; Ren S; Zhou Y; Sato N Oncol Lett; 2020 Nov; 20(5):199. PubMed ID: 32963605 [TBL] [Abstract][Full Text] [Related]
4. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells. Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma. Kudo Y; Kohi S; Hirata K; Goggins M; Sato N Oncotarget; 2019 Sep; 10(54):5592-5604. PubMed ID: 31608136 [No Abstract] [Full Text] [Related]
6. 4-methylumbelliferone inhibits clonogenic potency by suppressing high molecular weight-hyaluronan in fibrosarcoma cells. Hasegawa K; Saga R; Takahashi R; Fukui R; Chiba M; Okumura K; Tsuruga E; Hosokawa Y Oncol Lett; 2020 Apr; 19(4):2801-2808. PubMed ID: 32218833 [TBL] [Abstract][Full Text] [Related]
7. A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells. Kohi S; Sato N; Cheng XB; Koga A; Higure A; Hirata K Clin Exp Metastasis; 2016 Mar; 33(3):225-30. PubMed ID: 26589701 [TBL] [Abstract][Full Text] [Related]
8. Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. Sato N; Cheng XB; Kohi S; Koga A; Hirata K Acta Pharm Sin B; 2016 Mar; 6(2):101-5. PubMed ID: 27006892 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts. Galgoczi E; Jeney F; Katko M; Erdei A; Gazdag A; Sira L; Bodor M; Berta E; Ujhelyi B; Steiber Z; Gyory F; Nagy EV Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):27. PubMed ID: 32084270 [TBL] [Abstract][Full Text] [Related]
10. Increase of Tumor Infiltrating γδ T-cells in Pancreatic Ductal Adenocarcinoma Through Remodeling of the Extracellular Matrix by a Hyaluronan Synthesis Suppressor, 4-Methylumbelliferone. Suto A; Kudo D; Yoshida E; Nagase H; Suto S; Mimura J; Itoh K; Hakamada K Pancreas; 2019 Feb; 48(2):292-298. PubMed ID: 30589828 [TBL] [Abstract][Full Text] [Related]
11. Effects of 4-methylumbelliferone and high molecular weight hyaluronic acid on the inflammation of corneal stromal cells induced by LPS. Li F; Hao P; Liu G; Wang W; Han R; Jiang Z; Li X Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):559-566. PubMed ID: 27924359 [TBL] [Abstract][Full Text] [Related]
12. High-molecular-weight hyaluronan produced by activated pancreatic stellate cells promotes pancreatic cancer cell migration via paracrine signaling. Junliang L; Lili W; Xiaolong L; Xuguang L; Huanwen W; Zhiyong L Biochem Biophys Res Commun; 2019 Jul; 515(3):493-498. PubMed ID: 31171359 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor. Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer. Oba T; Sato N; Adachi Y; Amaike T; Kudo Y; Koga A; Kohi S; Hirata K Sci Rep; 2021 Sep; 11(1):18193. PubMed ID: 34521918 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer. Yoshida E; Kudo D; Nagase H; Shimoda H; Suto S; Negishi M; Kakizaki I; Endo M; Hakamada K Oncol Lett; 2016 Oct; 12(4):2337-2344. PubMed ID: 27698797 [TBL] [Abstract][Full Text] [Related]
17. The hyaluronan synthesis inhibitor 4-methylumbelliferone exhibits antitumor effects against mesenchymal-like canine mammary tumor cells. Saito T; Dai T; Asano R Oncol Lett; 2013 Mar; 5(3):1068-1074. PubMed ID: 23426189 [TBL] [Abstract][Full Text] [Related]
18. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804 [TBL] [Abstract][Full Text] [Related]
19. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Kultti A; Pasonen-Seppänen S; Jauhiainen M; Rilla KJ; Kärnä R; Pyöriä E; Tammi RH; Tammi MI Exp Cell Res; 2009 Jul; 315(11):1914-23. PubMed ID: 19285976 [TBL] [Abstract][Full Text] [Related]
20. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. David-Raoudi M; Deschrevel B; Leclercq S; Galéra P; Boumediene K; Pujol JP Arthritis Rheum; 2009 Mar; 60(3):760-70. PubMed ID: 19248106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]